Stereotaxis (id:186 STXS)
2.35 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 12/23/2024 7:59:44 PM)
Exchange closed, opens in 13 hours 30 minutes
About Stereotaxis
Market Capitalization 188.95M
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
Headquarters (address) |
710 North Tucker Boulevard Saint Louis 63101 MO United States |
Phone | 314 678 6100 |
Website | https://www.stereotaxis.com |
Employees | 122 |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Ticker | STXS |
Exchange | New York Stock Exchange |
Currency | USD |
52 week range | 1.66 - 3.29 |
Market Capitalization | 188.95M |
P/E trailing | -8.70 |
P/E forward | -12.39 |
Price/Sale | 7.51 |
Price/Book | 17.42 |
Beta | 1.55 |
EPS | 3.00 |
EPS United States (ID:6, base:3382) | 24.33 |